vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and OXFORD INDUSTRIES INC (OXM). Click either name above to swap in a different company.
OXFORD INDUSTRIES INC is the larger business by last-quarter revenue ($307.3M vs $205.4M, roughly 1.5× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -20.7%, a 29.0% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -0.2%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-47.9M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -3.0%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Oxford Industries, Inc. is a publicly traded clothing company in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Johnny Was and Southern Tide.
COLL vs OXM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $307.3M |
| Net Profit | $17.0M | $-63.7M |
| Gross Margin | 62.5% | 60.3% |
| Operating Margin | 29.6% | -27.7% |
| Net Margin | 8.3% | -20.7% |
| Revenue YoY | 12.9% | -0.2% |
| Net Profit YoY | 35.3% | -1517.6% |
| EPS (diluted) | $0.48 | $-4.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $307.3M | ||
| Q3 25 | $209.4M | $403.1M | ||
| Q2 25 | $188.0M | $392.9M | ||
| Q1 25 | $177.8M | — | ||
| Q4 24 | $181.9M | $308.0M | ||
| Q3 24 | $159.3M | $419.9M | ||
| Q2 24 | $145.3M | $398.2M | ||
| Q1 24 | $144.9M | $404.4M |
| Q4 25 | $17.0M | $-63.7M | ||
| Q3 25 | $31.5M | $16.7M | ||
| Q2 25 | $12.0M | $26.2M | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $12.5M | $-3.9M | ||
| Q3 24 | $9.3M | $40.6M | ||
| Q2 24 | $19.6M | $38.4M | ||
| Q1 24 | $27.7M | $-60.1M |
| Q4 25 | 62.5% | 60.3% | ||
| Q3 25 | 61.7% | 61.4% | ||
| Q2 25 | 57.7% | 64.2% | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | 63.1% | ||
| Q3 24 | 60.8% | 63.1% | ||
| Q2 24 | 62.5% | 64.9% | ||
| Q1 24 | 63.1% | 60.9% |
| Q4 25 | 29.6% | -27.7% | ||
| Q3 25 | 29.7% | 6.3% | ||
| Q2 25 | 18.7% | 9.2% | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 20.9% | -2.0% | ||
| Q3 24 | 21.9% | 12.5% | ||
| Q2 24 | 32.7% | 13.2% | ||
| Q1 24 | 34.1% | -20.1% |
| Q4 25 | 8.3% | -20.7% | ||
| Q3 25 | 15.0% | 4.1% | ||
| Q2 25 | 6.4% | 6.7% | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 6.9% | -1.3% | ||
| Q3 24 | 5.9% | 9.7% | ||
| Q2 24 | 13.5% | 9.6% | ||
| Q1 24 | 19.1% | -14.9% |
| Q4 25 | $0.48 | $-4.28 | ||
| Q3 25 | $0.84 | $1.12 | ||
| Q2 25 | $0.34 | $1.70 | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $0.36 | $-0.25 | ||
| Q3 24 | $0.27 | $2.57 | ||
| Q2 24 | $0.52 | $2.42 | ||
| Q1 24 | $0.71 | $-3.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $8.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $528.0M |
| Total Assets | $1.7B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $8.0M | ||
| Q3 25 | $285.9M | $6.9M | ||
| Q2 25 | $222.2M | $8.2M | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | $7.0M | ||
| Q3 24 | $120.0M | $18.4M | ||
| Q2 24 | $271.6M | $7.7M | ||
| Q1 24 | $318.0M | $7.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $29.0M |
| Q4 25 | $301.7M | $528.0M | ||
| Q3 25 | $274.8M | $597.1M | ||
| Q2 25 | $232.2M | $592.4M | ||
| Q1 25 | $234.4M | — | ||
| Q4 24 | $228.8M | $612.2M | ||
| Q3 24 | $234.3M | $621.6M | ||
| Q2 24 | $216.6M | $592.9M | ||
| Q1 24 | $222.2M | $560.9M |
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.1B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-9.1M |
| Free Cash FlowOCF − Capex | $122.4M | $-47.9M |
| FCF MarginFCF / Revenue | 59.6% | -15.6% |
| Capex IntensityCapex / Revenue | 0.3% | 12.6% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-79.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $-9.1M | ||
| Q3 25 | $78.4M | $83.5M | ||
| Q2 25 | $72.4M | $-3.9M | ||
| Q1 25 | $55.4M | — | ||
| Q4 24 | $84.6M | $-18.2M | ||
| Q3 24 | $-9.0M | $88.8M | ||
| Q2 24 | $67.4M | $32.9M | ||
| Q1 24 | $61.9M | $74.9M |
| Q4 25 | $122.4M | $-47.9M | ||
| Q3 25 | $78.3M | $52.3M | ||
| Q2 25 | $72.4M | $-27.4M | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | $-56.9M | ||
| Q3 24 | $-9.2M | $47.2M | ||
| Q2 24 | $67.1M | $21.0M | ||
| Q1 24 | $61.4M | $55.3M |
| Q4 25 | 59.6% | -15.6% | ||
| Q3 25 | 37.4% | 13.0% | ||
| Q2 25 | 38.5% | -7.0% | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | -18.5% | ||
| Q3 24 | -5.8% | 11.2% | ||
| Q2 24 | 46.2% | 5.3% | ||
| Q1 24 | 42.3% | 13.7% |
| Q4 25 | 0.3% | 12.6% | ||
| Q3 25 | 0.1% | 7.7% | ||
| Q2 25 | 0.0% | 6.0% | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | 12.6% | ||
| Q3 24 | 0.2% | 9.9% | ||
| Q2 24 | 0.2% | 3.0% | ||
| Q1 24 | 0.4% | 4.8% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 5.00× | ||
| Q2 25 | 6.05× | -0.15× | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | 2.19× | ||
| Q2 24 | 3.44× | 0.86× | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
